Market Value2,279,648,201
Total Holdings57
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
RYTM / Rhythm Pharmaceuticals, Inc.
BBIO / BridgeBio Pharma, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
NGNE / Neurogene Inc.
ATXS / Astria Therapeutics, Inc.
EDIT / Editas Medicine, Inc. Put
HARP / Harpoon Therapeutics, Inc.
NMRA / Neumora Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
VERV / Verve Therapeutics, Inc.
IMVT / Immunovant, Inc.
AMAM / Ambrx Biopharma Inc.
NKTX / Nkarta, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
BEAM / Beam Therapeutics Inc. Put
INSM / Insmed Incorporated
STOK / Stoke Therapeutics, Inc.
ACLX / Arcellx, Inc.
PHVS / Pharvaris N.V.
EYPT / EyePoint Pharmaceuticals, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
TARS / Tarsus Pharmaceuticals, Inc.
RAPT / RAPT Therapeutics, Inc.
IMRX / Immuneering Corporation
CRBP / Corbus Pharmaceuticals Holdings, Inc.
MLTX / MoonLake Immunotherapeutics
BCAB / BioAtla, Inc.
CABA / Cabaletta Bio, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
PRAX / Praxis Precision Medicines, Inc.
AVTE / Aerovate Therapeutics, Inc.
GHRS / GH Research PLC
CRNX / Crinetics Pharmaceuticals, Inc.
JANX / Janux Therapeutics, Inc.
BMEA / Biomea Fusion, Inc.
CRGX / CARGO Therapeutics, Inc.
MRSN / Mersana Therapeutics, Inc.
KYTX / Kyverna Therapeutics, Inc.
TRML / Tourmaline Bio, Inc.
VYNE / VYNE Therapeutics Inc.
ENGN / enGene Holdings Inc.
ARQT / Arcutis Biotherapeutics, Inc.
HLXB / Helix Acquisition Corp. II
CGON / CG Oncology, Inc.
MRUS / Merus N.V.
LNTH / Lantheus Holdings, Inc.
IRON / Disc Medicine, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
SNDX / Syndax Pharmaceuticals, Inc.
RYZB / RayzeBio, Inc.
CBAY / CymaBay Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
AXNX / Axonics, Inc.
SYRE / Spyre Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
CMPX / Compass Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
VTYX / Ventyx Biosciences, Inc.
APLS / Apellis Pharmaceuticals, Inc.
PCVX / Vaxcyte, Inc.
KRRO / Korro Bio, Inc.
EWTX / Edgewise Therapeutics, Inc.
AVBP / ArriVent BioPharma, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
BHVN / Biohaven Ltd.
MRNS / Marinus Pharmaceuticals, Inc.